世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000030760

世界のウイルスベクターおよびプラスミドDNA製造市場規模調査:ベクタータイプ別・エンドユース別・用途別・地域別の予測(2021年〜2027年)

Bizwit Research & Consulting LLP

Global Viral Vectors And Plasmid DNA Manufacturing Market Size study, by Vector type (Adenovirus, Retrovirus, Adeno-associated Virus (AAV), Lentivirus, Plasmid DNA, Others), by End-use (Pharmaceutical and Biopharmaceutical Companies, Research Institutes), by Application (Antisense & RNAi Therapy, Gene Therapy, Vaccinology, Research Applications), and Regional Forecasts 2021-2027

発刊日 2021/10/12

言語英語

体裁PDF/200ページ

ライセンス/価格200ページ

0000030760

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

世界のウイルスベクターおよびプラスミドDNA製造市場は、2020年には約22億米ドルとなり、2021年から2027年の予測期間には18.8%以上の健全な成長率が見込まれています。世界のウイルスベクターおよびプラスミドDNA製造市場は、遺伝子治療に関連する研究開発活動への資金提供の増加、癌、ウイルス感染症、遺伝性疾患の有病率の増加、および遺伝子治療に関する意識の高まりによって牽引されています。さらに、合成遺伝子の需要の増加は、世界のウイルスベクターおよびプラスミドDNA製造業界に新たな機会を提供するでしょう。例えば、国立癌研究機関によると、2018年の世界の癌の新規罹患者数は約1,810万人、癌による死亡者数は約950万人となっています。2040年には、1年間に新たに発生する癌患者数は2,950万人、癌による死亡者数は1,640万人に増加すると予想されています。その結果、癌患者の増加により、ウイルスベクターおよびプラスミドDNA製造の使用が必要となり、今後のウイルスベクターおよびプラスミドDNA製造業界の起爆剤となるでしょう。しかし、遺伝子治療に伴う高コスト、突然変異のリスク、その他の障害が、2021年から2027年の予測期間における市場の成長を妨げる可能性があります。

アジア太平洋地域、北アメリカ、ヨーロッパ、ラテンアメリカ、その他の地域は、ウイルスベクターおよびプラスミドDNA製造の地域分析のために考慮された主要地域です。先進的な治療法の研究開発に従事している多数のセンターや研究所が存在し、規制当局からの承認が増加していることから、北アメリカは市場シェアの点で世界の主要地域となっています。また、2021年から2027年の予測期間において、北アメリカは民間および政府の投資の増加と医療ニーズの高まりにより、最も高い成長率を示すと予想されています。

主要企業

  • Merck KGaA
  • Lonza.
  • FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
  • Cobra biologics ltd.
  • Thermo fisher scientific inc.
  • Waisman Biomanufacturing
  • Genezen laboratories
  • YPOSKESI
  • Advanced BioScience Laboratories, Inc. (ABL inc.)
  • Novasep holding s.a.s.

この調査の目的は、近年のさまざまなセグメントおよび国々の市場規模を定義し、今後8年間の価値を予測することです。本レポートは、調査対象となる各地域・国における産業の質的・量的側面を取り込むように設計されています。さらに、市場の今後の成長を決定づける推進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合状況や製品提供の詳細な分析とともに、利害関係者が投資するミクロ市場での機会についても報告します。

セグメント・サブセグメント

  • ベクタータイプ別
    ➣ アデノウイルス
    ➣ レトロウイルス
    ➣ アデノ随伴ウイルス(AAV)
    ➣ レンチウイルス
    ➣ プラスミドDNA
    ➣ その他
  • エンドユース別
    ➣ 製薬企業・バイオ製薬企業
    ➣ 研究機関
  • 用途別
    ➣ アンチセンス&RNAi療法
    ➣ 遺伝子治療
    ➣ ワクチン
    ➣ 研究
  • 地域別
    ➣ 北アメリカ
      ◇ アメリカ
      ◇ カナダ
    ➣ ヨーロッパ
      ◇ イギリス
      ◇ ドイツ
      ◇ フランス
      ◇ スペイン
      ◇ イタリア
      ◇ その他のヨーロッパ
    ➣ アジア太平洋地域
      ◇ 中国
      ◇ インド
      ◇ 日本
      ◇ オーストラリア
      ◇ 韓国
      ◇ その他のAPAC
    ➣ ラテンアメリカ
      ◇ ブラジル
      ◇ メキシコ
    ➣ 世界のその他の地域

調査対象の年

  • 実績データ - 2018年、2019年
  • 基準年 - 2020年
  • 予測期間 - 2021年から2027年

レポート詳細

目次

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Viral Vectors And Plasmid DNA Manufacturing Market , by Region, 2019-2027 (USD Billion)
1.2.2. Viral Vectors And Plasmid DNA Manufacturing Market , by Vector Type, 2019-2027 (USD Billion)
1.2.3. Viral Vectors And Plasmid DNA Manufacturing Market , by End Use, 2019-2027 (USD Billion)
1.2.4. Viral Vectors And Plasmid DNA Manufacturing Market , by Application, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Viral Vectors And Plasmid DNA Manufacturing Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Viral Vectors And Plasmid DNA Manufacturing Market Dynamics
3.1. Viral Vectors And Plasmid DNA Manufacturing Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increase in funding for R&D activities pertaining to gene therapy
3.1.1.2. Rise in prevalence of cancer, viral infections, and genetic disorders
3.1.1.3. Increase in awareness regarding gene therapies
3.1.2. Market Restraint
3.1.2.1. High cost associated with gene therapies
3.1.2.2. Risk of mutagenesis and other impediments in gene therapy
3.1.3. Market Opportunities
3.1.3.1. Increase in demand for synthetic genes

Chapter 4. Global Viral Vectors And Plasmid DNA Manufacturing Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Viral Vectors And Plasmid DNA Manufacturing Market , by Vector Type
5.1. Market Snapshot
5.2. Global Viral Vectors And Plasmid DNA Manufacturing Market by Vector Type, Performance - Potential Analysis
5.3. Global Viral Vectors And Plasmid DNA Manufacturing Market Estimates & Forecasts by Vector Type 2018-2027 (USD Billion)
5.4. Viral Vectors And Plasmid DNA Manufacturing Market , Sub Segment Analysis
5.4.1. Adenovirus
5.4.2. Retrovirus
5.4.3. Adeno-associated Virus (AAV)
5.4.4. Lentivirus
5.4.5. Plasmid DNA
5.4.6. Others

Chapter 6. Global Viral Vectors And Plasmid DNA Manufacturing Market , by End Use
a. Market Snapshot
6.1. Global Viral Vectors And Plasmid DNA Manufacturing Market by End Use, Performance - Potential Analysis
6.2. Global Viral Vectors And Plasmid DNA Manufacturing Market Estimates & Forecasts by End Use2018-2027 (USD Billion)
6.3. Viral Vectors And Plasmid DNA Manufacturing Market , Sub Segment Analysis
6.3.1. Pharmaceutical and Biopharmaceutical Companies
6.3.2. Research Institutes

Chapter 7. Global Viral Vectors And Plasmid DNA Manufacturing Market , by Application
b. Market Snapshot
7.1. Global Viral Vectors And Plasmid DNA Manufacturing Market by Application, Performance - Potential Analysis
7.2. Global Viral Vectors And Plasmid DNA Manufacturing Market Estimates & Forecasts by Application 2018-2027 (USD Billion)
7.3. Viral Vectors And Plasmid DNA Manufacturing Market , Sub Segment Analysis
7.3.1. Antisense & RNAi Therapy
7.3.2. Gene Therapy
7.3.3. Vaccinology
7.3.4. Research Applications

Chapter 8. Global Viral Vectors And Plasmid DNA Manufacturing Market , Regional Analysis
8.1. Viral Vectors And Plasmid DNA Manufacturing Market , Regional Market Snapshot
8.2. North America Viral Vectors And Plasmid DNA Manufacturing Market
8.2.1. U.S. Viral Vectors And Plasmid DNA Manufacturing Market
8.2.1.1. Vector Type breakdown estimates & forecasts, 2018-2027
8.2.1.2. End Use breakdown estimates & forecasts, 2018-2027
8.2.1.3. Application breakdown estimates & forecasts, 2018-2027
8.2.2. Canada Viral Vectors And Plasmid DNA Manufacturing Market
8.3. Europe Viral Vectors And Plasmid DNA Manufacturing Market Snapshot
8.3.1. U.K. Viral Vectors And Plasmid DNA Manufacturing Market
8.3.2. Germany Viral Vectors And Plasmid DNA Manufacturing Market
8.3.3. France Viral Vectors And Plasmid DNA Manufacturing Market
8.3.4. Spain Viral Vectors And Plasmid DNA Manufacturing Market
8.3.5. Italy Viral Vectors And Plasmid DNA Manufacturing Market
8.3.6. Rest of Europe Viral Vectors And Plasmid DNA Manufacturing Market
8.4. Asia-Pacific Viral Vectors And Plasmid DNA Manufacturing Market Snapshot
8.4.1. China Viral Vectors And Plasmid DNA Manufacturing Market
8.4.2. India Viral Vectors And Plasmid DNA Manufacturing Market
8.4.3. Japan Viral Vectors And Plasmid DNA Manufacturing Market
8.4.4. Australia Viral Vectors And Plasmid DNA Manufacturing Market
8.4.5. South Korea Viral Vectors And Plasmid DNA Manufacturing Market
8.4.6. Rest of Asia Pacific Viral Vectors And Plasmid DNA Manufacturing Market
8.5. Latin America Viral Vectors And Plasmid DNA Manufacturing Market Snapshot
8.5.1. Brazil Viral Vectors And Plasmid DNA Manufacturing Market
8.5.2. Mexico Viral Vectors And Plasmid DNA Manufacturing Market
8.6. Rest of The World Viral Vectors And Plasmid DNA Manufacturing Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Merck KGaA
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Lonza.
9.2.3. FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
9.2.4. Cobra biologics ltd.
9.2.5. Thermo fisher scientific inc.
9.2.6. Waisman Biomanufacturing
9.2.7. Genezen laboratories
9.2.8. YPOSKESI
9.2.9. Advanced BioScience Laboratories, Inc. (ABL inc.)
9.2.10. Novasep holding s.a.s.

Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

List of Tables
TABLE 2. Global Viral Vectors And Plasmid DNA Manufacturing Market , report scope
TABLE 3. Global Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by region 2018-2027 (USD Billion)
TABLE 4. Global Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by Vector Type 2018-2027 (USD Billion)
TABLE 5. Global Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by End Use2018-2027 (USD Billion)
TABLE 6. Global Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by Application 2018-2027 (USD Billion)
TABLE 7. Global Viral Vectors And Plasmid DNA Manufacturing Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 8. Global Viral Vectors And Plasmid DNA Manufacturing Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 9. Global Viral Vectors And Plasmid DNA Manufacturing Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 10. Global Viral Vectors And Plasmid DNA Manufacturing Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 11. Global Viral Vectors And Plasmid DNA Manufacturing Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 12. Global Viral Vectors And Plasmid DNA Manufacturing Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 13. Global Viral Vectors And Plasmid DNA Manufacturing Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 14. Global Viral Vectors And Plasmid DNA Manufacturing Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 15. Global Viral Vectors And Plasmid DNA Manufacturing Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 16. Global Viral Vectors And Plasmid DNA Manufacturing Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 17. Global Viral Vectors And Plasmid DNA Manufacturing Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 18. Global Viral Vectors And Plasmid DNA Manufacturing Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 19. Global Viral Vectors And Plasmid DNA Manufacturing Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 20. Global Viral Vectors And Plasmid DNA Manufacturing Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 21. Global Viral Vectors And Plasmid DNA Manufacturing Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 22. Global Viral Vectors And Plasmid DNA Manufacturing Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 23. U.S. Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 24. U.S. Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 25. U.S. Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 26. Canada Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 27. Canada Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 28. Canada Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 29. UK Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 30. UK Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 31. UK Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 32. Germany Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 33. Germany Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 34. Germany Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 35. France Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 36. France Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 37. France Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 38. Spain Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 39. Spain Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 40. Spain Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 41. Italy Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 42. Italy Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 43. Italy Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 44. ROE Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 45. ROE Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 46. ROE Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 47. China Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 48. China Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 49. China Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 50. India Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 51. India Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 52. India Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 53. Japan Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 54. Japan Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 55. Japan Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 56. Australia Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 57. Australia Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 58. Australia Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 59. South Korea Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 60. South Korea Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 61. South Korea Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 62. ROPAC Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 63. ROPAC Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 64. ROPAC Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 65. Brazil Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 66. Brazil Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 67. Brazil Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 68. Mexico Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 69. Mexico Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 70. Mexico Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 71. ROLA Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 72. ROLA Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 73. ROLA Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 74. ROW Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 75. ROW Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 76. ROW Viral Vectors And Plasmid DNA Manufacturing Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 77. List of secondary sources used in the study of global Viral Vectors And Plasmid DNA Manufacturing Market .
TABLE 78. List of primary sources used in the study of global Viral Vectors And Plasmid DNA Manufacturing Market .
TABLE 79. Years considered for the study.
TABLE 80. Exchange rates considered.

List of figures
FIG 1. Global Viral Vectors And Plasmid DNA Manufacturing Market , research methodology
FIG 2. Global Viral Vectors And Plasmid DNA Manufacturing Market , market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Viral Vectors And Plasmid DNA Manufacturing Market , key trends 2020
FIG 5. Global Viral Vectors And Plasmid DNA Manufacturing Market , growth prospects 2021-2027
FIG 6. Global Viral Vectors And Plasmid DNA Manufacturing Market , porters 5 force model
FIG 7. Global Viral Vectors And Plasmid DNA Manufacturing Market , pest analysis
FIG 8. Global Viral Vectors And Plasmid DNA Manufacturing Market , value chain analysis
FIG 9. Global Viral Vectors And Plasmid DNA Manufacturing Market by segment, 2018 & 2027 (USD Billion)
FIG 10. Global Viral Vectors And Plasmid DNA Manufacturing Market by segment, 2018 & 2027 (USD Billion)
FIG 11. Global Viral Vectors And Plasmid DNA Manufacturing Market by segment, 2018 & 2027 (USD Billion)
FIG 12. Global Viral Vectors And Plasmid DNA Manufacturing Market by segment, 2018 & 2027 (USD Billion)
FIG 13. Global Viral Vectors And Plasmid DNA Manufacturing Market by segment, 2018 & 2027 (USD Billion)
FIG 14. Global Viral Vectors And Plasmid DNA Manufacturing Market by segment, 2018 & 2027 (USD Billion)
FIG 15. Global Viral Vectors And Plasmid DNA Manufacturing Market by segment, 2018 & 2027 (USD Billion)
FIG 16. Global Viral Vectors And Plasmid DNA Manufacturing Market by segment, 2018 & 2027 (USD Billion)
FIG 17. Global Viral Vectors And Plasmid DNA Manufacturing Market , regional snapshot 2018 & 2027
FIG 18. North America Viral Vectors And Plasmid DNA Manufacturing Market 2018 & 2027 (USD Billion)
FIG 19. Europe Viral Vectors And Plasmid DNA Manufacturing Market 2018 & 2027 (USD Billion)
FIG 20. Asia-Pacific Viral Vectors And Plasmid DNA Manufacturing Market 2018 & 2027 (USD Billion)
FIG 21. Latin America Viral Vectors And Plasmid DNA Manufacturing Market 2018 & 2027 (USD Billion)
FIG 22. Global Viral Vectors And Plasmid DNA Manufacturing Market , company market share analysis (2020)

この商品のレポートナンバー

0000030760

TOP